|
Table of Contents
Terms Used In This Article
benign intracranial hypertension - another name used to refer to
idiopathic intracranial hypertension
fenestrate - create perforations or openings
idiopathic - due to an unknown cause
idiopathic intracranial hypertension (IIH) - condition where a person
suffers from elevated intracranial pressure with no visible cause
intracranial pressure (ICP) - the pressure of the cerebrospinal fluid
in the skull
lumbar puncture (LP) - procedure where a needle is inserted into the
CSF space of the lower back region; can be used to remove CSF or insert
drugs
optic nerve - large bundle of nerve fibers which connect the eye to
the visual region of the brain, critical for visual function
pseudotumor cerebri (PTC) - another name for idiopathic intracranial
hypertension; not used as much anymore
shunt - a small tube which is inserted into the body to divert spinal
fluid
Common Chiari Terms
cerebellar tonsils -
portion of the cerebellum located at the bottom, so named because of their
shape
cerebellum - part of
the brain located at the bottom of the skull, near the opening to the spinal
area; important for muscle control, movement, and balance
cerebrospinal fluid (CSF) - clear liquid in the brain and spinal
cord, acts as a shock absorber
Chiari malformation I -
condition where the cerebellar tonsils are displaced out of the skull area
into the spinal area, causing compression of brain tissue and disruption of
CSF flow
decompression surgery -
general term used for any of several surgical techniques employed to
create more space around a Chiari malformation and to relieve compression
|
April 20, 2006 -- Idiopathic intracranial hypertension (IIH), also
known as pseudotumor cerebri (PTC) and benign intracranial hypertension, is
a condition characterized by an increase in intracranial pressure (the
pressure of spinal fluid in the head) with no apparent cause. Like
Chiari, its main symptom is a pressure headache, made worse by straining,
coughing, etc. Since both IIH and Chiari are fundamentally
tied to the CSF system, perhaps it should not be surprising that there
appears to be some type of connection between the two.
Recently, there have been a couple of studies published
which indicate that a percentage of Chiari surgeries fail due to the
presence of IIH in addition to Chiari. However, this research is
early-stage, and the exact link between Chiari and IIH is not understood.
It could be that the sustained increase in pressure associated with IIH
eventually leads the cerebellum to herniate out of the skull and creates a
Chiari malformation. If this were the case, then decompression surgery
would help symptoms associated with direct compression of the malformation,
but would not relieve the symptoms associated with the elevated pressure of
IIH.
It may also be the case that the blockage caused by a
Chiari malformation, which we know can elevate the intracranial pressure,
may lead to a fundamental change in the CSF system and eventually IIH.
In this case, even though the region around the Chiari malformation is
decompressed surgically, for unknown reasons, the intracranial pressure
remains high.
A third possibility is that both Chiari and IIH are
manifestations of a more fundamental problem, such as a too small posterior
fossa (the skull region where the cerebellum sits). Perhaps some
people with a small or abnormally shaped skull develop IIH, while others
develop Chiari, and still others develop both.
Finally, it may be that Chiari surgery itself plays a
role in the development of IIH. There appear to be some cases where
symptoms associated with IIH don't appear until after Chiari surgery.
How, and even if, decompression surgery could lead to IIH is not at all
clear.
While the nature of the connection is a mystery, and
likely will turn out to be a combination of the possibilities listed above,
the importance of IIH in the context of Chiari is clear. Although they
didn't mention IIH's apparent relationship to Chiari, a group from Denmark (Skau,
Brennum, Gjerris, Jensen) recently published a very informative review of
IIH in the April, 2006 edition of the journal Cephalagia. The
following description of IIH is based upon that review.
As mentioned previously idiopathic intracranial
hypertension is a condition involving elevated pressure of the CSF in the
brain region due to an unknown cause. Idiopathic is a term used to
mean of unknown origin; intracranial means within the skull; and
hypertension means raised, or elevated, pressure. IIH was first
described in 1937 and has remained largely a mystery ever since.
Being idiopathic, by its very nature, IIH is difficult
to define and diagnose. The name IIH really only applies when no cause
can be found, and IIH likely encompasses a number of related conditions.
Over the years, as different, specific conditions which lead to elevated ICP
have been identified, they have been split off from IIH and labeled
separately (perhaps one day, Chiari related intracranial hypertension will
be thought of differently than IIH).
Because of this, IIH is largely diagnosed by excluding
other possibilities. If a patient (especially an obese woman as will
be explained below) has symptoms of elevated ICP, the suspected pressure can
be confirmed through an eye exam and or a lumbar puncture. Once
confirmed, the treating physician will look for any of a myriad of potential
causes of elevated ICP, including: tumors, vascular disease,
infections, drug reactions, and circulatory problems to name a few.
Once all other causes are ruled out, the condition is considered to be
idiopathic in nature, or IIH.
Given its somewhat obscure definition, the number of
people affected by IIH is not known. However, like Chiari, recently
there has been a rapid rise in diagnoses. It appears to effect women
more than men, perhaps as much as 15 to 1, and IIH is especially common
among obese women. In fact, some studies of IIH have found that as
many as 70% of IIH patients were obese women. Interestingly, among
children there appears to be no difference between the number of boys and
girls affected, and a link to obesity in adult men has not been identified.
Although the most common symptom is a pressure
headache, symptoms also include double vision, visual blurring, nausea,
vomiting, dizziness, and ringing in the ears (see Table 1). The most serious symptom
associated with IIH is vision loss. The sustained pressure associated
with IIH can eventually damage the optic nerve - the bundle of fibers which
connect the eye to the brain - and if not treated can lead serious vision
problems.
Since the cause of IIH is unknown, treatments tend to
focus on the symptoms and can involve drugs or surgery. Unfortunately,
to date there have not been any rigorous studies comparing the effectiveness
of drug treatments versus surgery.
On the medicine side, acetazalomide is commonly one of
the first drugs tried. It is believed to act by reducing the
production of cerebrospinal fluid and thus leads to a decrease in ICP.
If the acetazalomide does not work, it is sometimes supplemented with a
second medicine, furosemide. Recently, an anti-convulsant, topiramate,
has been reported to be used to treat IIH, but more research is
required to determine its effectiveness. In addition to treating the
symptoms with medicine, if the patient is obese, weight loss has been shown
to be an effective approach to alleviating symptoms.
On the surgical side, a shunt can be inserted to divert
CSF and lower the pressure in the head. While shunting is very
effective in relieving symptoms, a patient then has to deal with potential
problems related to having a shunt inside of them; namely mechanical
malfunction and infection. Such problems are not uncommon can lead to the need for
additional surgeries to revise or replace the shunt.
For a patient whose vision is at risk, a surgeon may
elect to decompress the optic nerve by perforating the sheath over the nerve
bundle. This reduces pressure on the nerve and according to published
reports is usually successful in stabilizing or improving visual function.
However, this type of surgery does not address the problem of elevated
pressure directly and relief from other IIH symptoms is not as great.
One approach to treating IIH which may be falling out
of favor is to repeatedly drain CSF through lumbar punctures. Draining
a large quantity of CSF in this way usually provides temporary relief from
symptoms, but again does not really address the underlying problem.
Overall, treatments for IIH are effective for a
majority of people. Research has found that 70% or more of patients
experience symptom relief or resolution within a couple months of starting
treatment. However, there does appear to be a subset of patients,
perhaps as many as 25%, for whom IIH becomes a long, difficult battle.
In addition, much like Chiari, recurrence of symptoms, even years down the
road, has been noted.
Although the exact mechanism which leads to the
increased pressure in IIH is not known, from an abstract point of view there
are several possibilities: increased production of CSF, abnormal
absorption of CSF, increased brain mass, and obstruction of blood outflow
from the brain. However, and somewhat surprisingly, research has
failed to consistently find any of the above to be the problem in IIH
patients. Interestingly, studies have shown an increase in resistance
to CSF flow (much like exists with Chiari) in 75% or more of IIH patients.
For now, IIH remains largely a poorly understood condition,
but with its connection to the CSF system, similar symptoms, and presence in
a subset of Chiari patients, it appears IIH is a Chiari cousin worth staying
in touch with.
-- Rick Labuda
Back to Table of Contents |
Key Points
-
Pseudotumor cerebri, or idiopathic
intracranial hypertension (IIH). is a disorder involving elevated
intracranial pressure with no visible cause
-
There appears to be a link between
IIH and Chiari; either a subset of Chiari patients also have IIH or one
causes the other or surgery can lead to IIH
-
Most common symptom of IIH is
pressure headache, made worse with straining
-
Visual problems are also common and
permanent visual damage is a concern
-
Treated with drugs; sometimes the
optic nerve is surgically decompressed to preserve visual function
-
More common in women than men;
especially common among obese women
-
About 70% get better with treatment
in 3 months or less, but about 25% experience protracted symptoms
Table 1
Common Symptoms Of Idiopathic Intracranial Hypertension
| |
Study 1 |
Study 2 |
Study 3 |
| # of Patients |
62 |
63 |
57 |
| Headache (%) |
95 |
75 |
81 |
| Double Vision (%) |
31 |
35 |
33 |
| Visual Blurring |
65 |
68 |
72 |
| Nausea, Vomiting |
24 |
21 |
-- |
Note: Study 1:
Johnston et al., Brain 1974; Study 2: Rush et al., Mayo Clin Proc
1980; Study 3: Corbett et al., Arch Neurol 1982 Source:
Skau M, Brennum J, Gjerris F, Jensen R.
What is new about idiopathic intracranial hypertension? An updated review of
mechanism and treatment.
Cephalalgia. 2006 Apr;26(4):384-99
Related C&S News Articles:
More Evidence That Pseudotumor Cerebri Plays A
Role In Failed Chiari Surgeries
Trying to identify why surgeries fail
Dr. Ghassan Bejjani, Neurosurgeon
and Chiari Researcher |